CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo
Abdullah Alajati(Institute of Oncology Research), Andrea Alimonti(Veneto Institute of Molecular Medicine)
Cited by 45
Related Papers
Cellular Senescence: Aging, Cancer, and Injury
|Physiological Reviews|2019|1.3k
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer
|Nature Genetics|2018|195
Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer
|Nature Communications|2022|116